<DOC>
	<DOCNO>NCT00298779</DOCNO>
	<brief_summary>This open-label , randomize , multiple-dose , multicenter Pharmacokinetics drug-drug interaction study patient advance solid tumor , include non-Hodgkin 's lymphoma , need anti-tumor therapy . In addition , impact omeprazole pharmacodynamics VELCADE also evaluate .</brief_summary>
	<brief_title>Open-Label Study Assess Effect Omeprazole Pharmacokinetics VELCADE Patients With Either Advanced Solid Tumors Non-Hodgkin 's Lymphoma .</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Bortezomib</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<criteria>1 ) Male female least 18 y/o 2 ) Weigh &gt; /= 50 kg ( 110lbs ) BMI &lt; /= 28kg/m2 ; 3 ) life expectancy &gt; /= 3 mo ; 4 ) Karnofsky Performance Status &gt; /=70 % ; 5 ) Women must menopausal . 3 ) Men must agree use acceptable method contraception duration study.4 ) Must sign inform consent document indicate understand purpose procedure require study ; 5 ) inform consent genetic test 6 ) Subjects advance solid tumor ( include nonHodgkin 's lymphoma ) .7 ) resolution reversible toxicity consider related prior antineoplastic therapy entry ; 8 ) must able swallow capsule whole ; 1 ) Prior exposure VELCADE.2 ) Has know hypersensitivity intolerance omeprazole , boron , mannitol heparin . 3 ) Medical history liver renal insufficiency ; significant cardiac , vascular , pulmonary , GI , endocrine , neurologic , rheumatologic , pyschiatric metabolic disturbance . 4 ) Uncontrolled diabetes . 5 ) history hypotension decrease blood pressure ; 6 ) Uncontrolled severe cardiovascular disease incl . myocardial infarction within 6 mos enrollment ; 7 ) History alcohol/drug abuse . 8 ) Presence HIV antibody , hepatitis C antibodies hepatitis B . 9 ) active systemic infection require treatment ; 10 ) Pregnant breastfeed ' 11 ) neuropathy &gt; /= Gr.1 ; 12 ) transfusion dependence ; 12 ) preplanned surgery procedure would interfere conduct study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>patient advance solid tumor Non-Hodgkins 's Lymphoma</keyword>
</DOC>